| Old Articles: <Older 13991-14000 Newer> |
 |
The Motley Fool May 2, 2006 Ryan Fuhrmann |
Sigma-Aldrich Surpasses Average Don't be fooled by appearances -- this isn't your typical chemical company. The shares have had a nice run over the past year, from about $55 to around $68.39. Even at current levels, the shares may be worth picking up, since they appear fairly valued.  |
The Motley Fool May 2, 2006 Stephen D. Simpson |
The Slowdown Begins at Building Materials If the selling gets too carried away, Building Materials Holding's stock may emerge as a value.  |
The Motley Fool May 2, 2006 Stephen D. Simpson |
Code Brown on HCA Under the current rules, running a hospital is virtually a no-win situation. HCA is likely a fine hospital operator, but this is an industry doomed to take body blows from almost every constituency it serves or interacts with.  |
The Motley Fool May 2, 2006 Jim Mueller |
Buffalo Wild Wings Flapping Harder Off to a good start, now this wing chain has to show what it's made of. Investors, take note.  |
The Motley Fool May 2, 2006 Stephen D. Simpson |
Playing Chicken With Chickens This was a tough quarter at Pilgrim's Pride, and management isn't suggesting we look for an immediate turnaround. These are tough times for most protein producers. Investors, take note.  |
The Motley Fool May 2, 2006 Anders Bylund |
Tough Times Ahead for PortalPlayer The chip supplier offers humbling news and a bleak outlook. Investors, take note.  |
The Motley Fool May 2, 2006 Stephen D. Simpson |
Can Genesee & Wyoming Juice Its Caboose? This is a likable short-line operator, but organic volume growth is an issue for investors.  |
The Motley Fool May 2, 2006 Alyce Lomax |
Insane CEO Pay As investors, it can often be sobering to take a hard look at management compensation information in a company's proxy materials. Should shareholders say enough's enough?  |
The Motley Fool May 2, 2006 Stephen D. Simpson |
A Peek at Chesapeake An investment here is largely a bet on natural gas prices. Chesapeake looks very interesting, particularly for the long-term.  |
The Motley Fool May 2, 2006 Stephen D. Simpson |
Still Fishing for Value at Fisher At the right price, this would be an interesting play on health care and biomedical research. Investors, take note.  |
| <Older 13991-14000 Newer> Return to current articles. |